| Typicality: | 0.384 |
| Saliency: | 0.518 |
| in treating prostate cancer | 3 | other |
| very | 3 | degree |
| peptide → be → beneficial | 3 |
| peptide → be → effective | 3 |
| peptide → be → active | 3 |
| negative | neutral | positive |
| 0.028 | 0.360 | 0.612 |
| Raw frequency | 9 |
| Normalized frequency | 0.518 |
| Modifier score | 0.500 |
| Perplexity | 70.535 |